@gga - I had my eyes on couple of other bio stocks that will likely be huge movers over the next 5 years. From memory, my research is sitting somewhere in the back corner of my office, covered in dust and cobwebs, situated behind the mountains of paperwork on Anteo.
But in all seriousness, if GC's marketing expertise can keep up with the virtually unlimited applications that surround this technology, you won't need another investment.
Could be wrong. DYOR.
crunch these numbers, page-21
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.003(11.5%) |
Mkt cap ! $72.20M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.7¢ | 2.9¢ | $1.433M | 44.19M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 870964 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 511263 | 4 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |